<VariationArchive VariationID="632969" VariationName="NR_003051.3(RMRP):n.-24_-4dup" VariationType="Duplication" Accession="VCV000632969" Version="10" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2019-06-03" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="621792" VariationID="632969">
      <GeneList>
        <Gene Symbol="RMRP" FullName="RNA component of mitochondrial RNA processing endoribonuclease" GeneID="6023" HGNC_ID="HGNC:10031" Source="submitted" RelationshipType="near gene, upstream">
          <Location>
            <CytogeneticLocation>9p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="35657750" stop="35658019" display_start="35657750" display_stop="35658019" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="35657747" stop="35658014" display_start="35657747" display_stop="35658014" Strand="-" />
          </Location>
          <OMIM>157660</OMIM>
        </Gene>
      </GeneList>
      <Name>NR_003051.3(RMRP):n.-24_-4dup</Name>
      <CanonicalSPDI>NC_000009.12:35658021:TCCTCAGCTTCACAGAGTAGT:TCCTCAGCTTCACAGAGTAGTTCCTCAGCTTCACAGAGTAGT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="35658021" stop="35658022" display_start="35658021" display_stop="35658022" variantLength="21" positionVCF="35658021" referenceAlleleVCF="G" alternateAlleleVCF="GTCCTCAGCTTCACAGAGTAGT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="35658018" stop="35658019" display_start="35658018" display_stop="35658019" variantLength="21" positionVCF="35658018" referenceAlleleVCF="G" alternateAlleleVCF="GTCCTCAGCTTCACAGAGTAGT" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.35658019_35658039dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.35658019_35658039dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.35658022_35658042dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.35658022_35658042dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_017041.1" sequenceAccession="NG_017041" sequenceVersion="1" change="g.4977_4997dup">
            <Expression>NG_017041.1:g.4977_4997dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033120.1" sequenceAccession="NG_033120" sequenceVersion="1" change="g.4733_4753dup">
            <Expression>NG_033120.1:g.4733_4753dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_116211.1" sequenceAccession="NG_116211" sequenceVersion="1" change="g.558_578dup">
            <Expression>NG_116211.1:g.558_578dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_163" sequenceAccession="LRG_163">
            <Expression>LRG_163:g.4977_4997dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_163t1" sequenceAccession="LRG_163t1">
            <Expression>LRG_163t1:n.-24_-4dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1563907883" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NR_003051.3(RMRP):n.-24_-4dup AND Metaphyseal chondrodysplasia, McKusick type" Accession="RCV000780685" Version="10">
        <ClassifiedConditionList TraitSetID="3926">
          <ClassifiedCondition DB="MedGen" ID="C0220748">Metaphyseal chondrodysplasia, McKusick type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NR_003051.3(RMRP):n.-24_-4dup AND Anauxetic dysplasia" Accession="RCV001204853" Version="12">
        <ClassifiedConditionList TraitSetID="39854">
          <ClassifiedCondition DB="MedGen" ID="C1846796">Anauxetic dysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NR_003051.3(RMRP):n.-24_-4dup AND multiple conditions" Accession="RCV002507350" Version="8">
        <ClassifiedConditionList TraitSetID="9781">
          <ClassifiedCondition DB="MedGen" ID="C4551965">Anauxetic dysplasia 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0220748">Metaphyseal chondrodysplasia, McKusick type</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1834821">Metaphyseal dysplasia without hypotrichosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-09" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-12-14" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2019-06-03" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11207361</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12107819</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16244706</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16254002</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18804272</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21396580</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21956908</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-31">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-05-15">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-01-05">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9781" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1318" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Metaphyseal chondrodysplasia, McKusick type</ElementValue>
                <XRef ID="7720002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cartilage-Hair Hypoplasia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CHH</ElementValue>
                <XRef Type="MIM" ID="250250" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6996" />
                <XRef ID="6996" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The cartilage-hair hypoplasia – anauxetic dysplasia (CHH-AD) spectrum disorders are a continuum that includes the following phenotypes: Metaphyseal dysplasia without hypotrichosis (MDWH). Cartilage-hair hypoplasia (CHH). Anauxetic dysplasia (AD). CHH-AD spectrum disorders are characterized by severe disproportionate (short-limb) short stature that is usually recognized in the newborn, and occasionally prenatally because of the short extremities. Other findings include joint hypermobility, fine silky hair, immunodeficiency, anemia, increased risk for malignancy, gastrointestinal dysfunction, and impaired spermatogenesis. The most severe phenotype, AD, has the most pronounced skeletal phenotype, may be associated with atlantoaxial subluxation in the newborn, and may include cognitive deficiency. The clinical manifestations of the CHH-AD spectrum disorders are variable, even within the same family.</Attribute>
                <XRef ID="NBK84550" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22420014</ID>
                <ID Source="BookShelf">NBK84550</ID>
              </Citation>
              <XRef ID="175" DB="Orphanet" />
              <XRef ID="C0220748" DB="MedGen" />
              <XRef ID="MONDO:0009595" DB="MONDO" />
              <XRef Type="MIM" ID="250250" DB="OMIM" />
            </Trait>
            <Trait ID="2910" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cartilage-hair hypoplasia-like skeletal dysplasia without hypotrichosis or immunodeficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cartilage-hair hypoplasia variant, skeletal manifestations only</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Metaphyseal dysplasia without hypotrichosis</ElementValue>
                <XRef ID="Metaphyseal+dysplasia+without+hypotrichosis/4702" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009601" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CHHV</ElementValue>
                <XRef Type="MIM" ID="250460" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10622" />
                <XRef ID="10622" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The cartilage-hair hypoplasia – anauxetic dysplasia (CHH-AD) spectrum disorders are a continuum that includes the following phenotypes: Metaphyseal dysplasia without hypotrichosis (MDWH). Cartilage-hair hypoplasia (CHH). Anauxetic dysplasia (AD). CHH-AD spectrum disorders are characterized by severe disproportionate (short-limb) short stature that is usually recognized in the newborn, and occasionally prenatally because of the short extremities. Other findings include joint hypermobility, fine silky hair, immunodeficiency, anemia, increased risk for malignancy, gastrointestinal dysfunction, and impaired spermatogenesis. The most severe phenotype, AD, has the most pronounced skeletal phenotype, may be associated with atlantoaxial subluxation in the newborn, and may include cognitive deficiency. The clinical manifestations of the CHH-AD spectrum disorders are variable, even within the same family.</Attribute>
                <XRef ID="NBK84550" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22420014</ID>
                <ID Source="BookShelf">NBK84550</ID>
              </Citation>
              <XRef ID="1838" DB="Orphanet" />
              <XRef ID="C1834821" DB="MedGen" />
              <XRef ID="MONDO:0009601" DB="MONDO" />
              <XRef Type="MIM" ID="250460" DB="OMIM" />
            </Trait>
            <Trait ID="302" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Anauxetic dysplasia 1</ElementValue>
                <XRef ID="MONDO:0054560" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spondylometaepiphyseal dysplasia Anauxetic type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spondylometaepiphyseal dysplasia Menger type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ANXD1</ElementValue>
                <XRef Type="MIM" ID="607095" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The cartilage-hair hypoplasia – anauxetic dysplasia (CHH-AD) spectrum disorders are a continuum that includes the following phenotypes: Metaphyseal dysplasia without hypotrichosis (MDWH). Cartilage-hair hypoplasia (CHH). Anauxetic dysplasia (AD). CHH-AD spectrum disorders are characterized by severe disproportionate (short-limb) short stature that is usually recognized in the newborn, and occasionally prenatally because of the short extremities. Other findings include joint hypermobility, fine silky hair, immunodeficiency, anemia, increased risk for malignancy, gastrointestinal dysfunction, and impaired spermatogenesis. The most severe phenotype, AD, has the most pronounced skeletal phenotype, may be associated with atlantoaxial subluxation in the newborn, and may include cognitive deficiency. The clinical manifestations of the CHH-AD spectrum disorders are variable, even within the same family.</Attribute>
                <XRef ID="NBK84550" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22420014</ID>
                <ID Source="BookShelf">NBK84550</ID>
              </Citation>
              <XRef ID="93347" DB="Orphanet" />
              <XRef ID="C4551965" DB="MedGen" />
              <XRef ID="MONDO:0054560" DB="MONDO" />
              <XRef Type="MIM" ID="607095" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3926" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1318" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Metaphyseal chondrodysplasia, McKusick type</ElementValue>
                <XRef ID="7720002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cartilage-Hair Hypoplasia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CHH</ElementValue>
                <XRef Type="MIM" ID="250250" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6996" />
                <XRef ID="6996" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The cartilage-hair hypoplasia – anauxetic dysplasia (CHH-AD) spectrum disorders are a continuum that includes the following phenotypes: Metaphyseal dysplasia without hypotrichosis (MDWH). Cartilage-hair hypoplasia (CHH). Anauxetic dysplasia (AD). CHH-AD spectrum disorders are characterized by severe disproportionate (short-limb) short stature that is usually recognized in the newborn, and occasionally prenatally because of the short extremities. Other findings include joint hypermobility, fine silky hair, immunodeficiency, anemia, increased risk for malignancy, gastrointestinal dysfunction, and impaired spermatogenesis. The most severe phenotype, AD, has the most pronounced skeletal phenotype, may be associated with atlantoaxial subluxation in the newborn, and may include cognitive deficiency. The clinical manifestations of the CHH-AD spectrum disorders are variable, even within the same family.</Attribute>
                <XRef ID="NBK84550" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22420014</ID>
                <ID Source="BookShelf">NBK84550</ID>
              </Citation>
              <XRef ID="175" DB="Orphanet" />
              <XRef ID="C0220748" DB="MedGen" />
              <XRef ID="MONDO:0009595" DB="MONDO" />
              <XRef Type="MIM" ID="250250" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="39854" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="37896" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE</ElementValue>
                <XRef Type="MIM" ID="607095" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Anauxetic dysplasia</ElementValue>
                <XRef ID="Anauxetic+Dysplasia/425" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011773" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS607095" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9657" />
                <XRef ID="9657" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="93347" DB="Orphanet" />
              <XRef ID="C1846796" DB="MedGen" />
              <XRef ID="MONDO:0011773" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS607095" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5454038" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NR_003051.3:n.-24_-4dup|OMIM:250250;250460;607095" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002798283" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NR_003051.3:n.-24_-4dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="250250" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="250460" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607095" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1794773" SubmissionDate="2023-01-11" DateLastUpdated="2023-01-15" DateCreated="2019-06-03">
        <ClinVarSubmissionID localKey="NC_000009.11:g.35658019_35658039dup21|MedGen:C0220748" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000918153" DateUpdated="2023-01-15" DateCreated="2019-06-03" Type="SCV" Version="3" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16244706</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18804272</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16254002</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21956908</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21396580</ID>
          </Citation>
          <Comment>Variant summary: RMRP n.-24_-4dup21 (also known as n.-25_-5dup21) involves the duplication of 21 nucleotides in the promoter region of RMRP, located between the TATA box (-33 to -25) and the transcription initiation site (at +1). The variant was absent in 128022 control chromosomes (gnomAD). n.-24_-4dup21 has been reported in the literature in the compound heterozygous state in individuals affected with Cartilage-Hair Hypoplasia (CHH) (e.g. Bonafe_2005, Kavadas_2008), including one family in which three affected siblings with the same compound heterozygous genotype presented with variable phenotypes: one affected with CHH, one with SCID, and one with CID+CD8 lymphopenia (Kavadas_2008). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. However, experimental studies have demonstrated that many other insertions and duplications in the promoter region of RMRP lead to reduced RMRP transcription (e.g. PMIDs: 11207361, 16254002). One clinical diagnostic laboratory has submitted a clinical-significance assessment for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RMRP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.35658019_35658039dup21</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0220748" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12529442</SubmissionName>
          <SubmissionName>SUB8831147</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2710816" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="7051885|MedGen:C1846796" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001376080" DateUpdated="2024-02-20" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16244706</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11207361</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12107819</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11207361</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16254002</ID>
          </Citation>
          <Comment>This variant occurs in the RMRP gene, which encodes an RNA molecule that does not result in a protein product. This variant is not present in population databases (gnomAD no frequency). While this particular variant has not been reported in the literature, it is located in the promoter region between the TATA box and the transcription initiation site, and other insertions and duplications immediately upstream of the coding sequence have been reported in individuals affected with cartilage-hair hypoplasia-anauxetic dysplasia (CHH-AD) spectrum disorders (PMID: 16244706, 11207361, 12107819). While functional studies for this variant have not been reported, experimental analyses using patient derived cells, as well as in vitro transfection studies, have shown that promoter insertions result in silencing of RMRP transcription and reduced expression of the gene product (PMID: 11207361, 16254002). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RMRP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.35658018_35658019insTCCTCAGCTTCACAGAGTAGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1846796" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5454038" TraitType="Disease" MappingType="XRef" MappingValue="607095" MappingRef="OMIM">
        <MedGen CUI="C4551965" Name="Anauxetic dysplasia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5454038" TraitType="Disease" MappingType="XRef" MappingValue="250460" MappingRef="OMIM">
        <MedGen CUI="C1834821" Name="Metaphyseal dysplasia without hypotrichosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2710816" TraitType="Disease" MappingType="XRef" MappingValue="C1846796" MappingRef="MedGen">
        <MedGen CUI="C1846796" Name="Anauxetic dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5454038" TraitType="Disease" MappingType="XRef" MappingValue="250250" MappingRef="OMIM">
        <MedGen CUI="C0220748" Name="Metaphyseal chondrodysplasia, McKusick type" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1794773" TraitType="Disease" MappingType="XRef" MappingValue="C0220748" MappingRef="MedGen">
        <MedGen CUI="C0220748" Name="Metaphyseal chondrodysplasia, McKusick type" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

